Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid

被引:3
作者
Chakravarti, N
Saadati, HG
El-Naggar, AK
Lotan, R
Diba, RE
Esmaeli, B [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Sect Ophthalmol, Dept Plast Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
D O I
10.1097/01.iop.0000172180.94824.79
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study retinoid receptor expression in sebaceous cell carcinoma of the eyelid Methods: Expression of retinoid receptors (RAR alpha, beta, and gamma and RXR alpha, beta, and gamma) in tumor specimens from 10 patients with sebaceous cell carcinoma of the eyelid and in 3 normal incidental tarsus specimens from healthy adults without cancer was studied immunohistochemically by using antiretinoid receptor antibodies. Results: In all 3 specimens of normal tarsus, all 6 retinoid receptors were expressed. RAR alpha expression was absent in 3 tumors and was decreased in 3 tumors compared with expression in the control tissues. RAR beta expression in carcinomas was primarily perinuclear; 6 tumors showed increased RAR beta expression compared with controls. RAR gamma expression was absent in 4 tumors and was decreased in 2 tumors compared with controls. RXR alpha nuclear expression was decreased compared with controls in 5 tumors. RXR beta expression was low in 7 tumors. RXR gamma expression was absent in 6 tumors. Conclusions: Aberrant expression of retmoid receptors in sebaceous cell carcinoma of the eyelid might play a role in the pathogenesis and progression of this carcinoma.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 43 条
[1]   Predictive impact of retinoid X receptor-alpha-expression in renal-cell carcinoma [J].
Buentig, N ;
Stoerkel, S ;
Richter, E ;
Dallmann, I ;
Reitz, M ;
Atzpodien, J .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (03) :331-342
[2]  
Chakravarti N, 2001, INT J CANCER, V91, P27, DOI 10.1002/1097-0215(20010101)91:1<27::AID-IJC1003>3.0.CO
[3]  
2-K
[4]  
CHAKRAVARTI N, IN PRESS J CUTANEOUS
[5]   Retinoic acid receptor-β expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium [J].
Chang, YS ;
Chung, JH ;
Shin, DH ;
Chung, KY ;
Kim, YS ;
Chang, J ;
Kim, SK ;
Kim, SK .
YONSEI MEDICAL JOURNAL, 2004, 45 (03) :435-442
[6]   Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion [J].
Chao, AN ;
Shields, CL ;
Krema, H ;
Shields, JA .
OPHTHALMOLOGY, 2001, 108 (10) :1877-1883
[7]   Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled [J].
Chapellier, B ;
Mark, M ;
Messaddeq, N ;
Calléja, C ;
Warot, X ;
Brocard, J ;
Gérard, C ;
Li, M ;
Metzger, D ;
Ghyselinck, NB ;
Chambon, P .
EMBO JOURNAL, 2002, 21 (13) :3402-3413
[8]   RXR alpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids [J].
Clifford, J ;
Chiba, H ;
Sobieszczuk, D ;
Metzger, D ;
Chambon, P .
EMBO JOURNAL, 1996, 15 (16) :4142-4155
[9]  
DARWICHE N, 1995, CANCER RES, V55, P2774
[10]  
DE LUCA LM, 1991, FASEB J, V5, P2924